Number of Infection Events Per Cell During HIV-1 Cell-free Infection
Authors
Affiliations
HIV-1 accumulates changes in its genome through both recombination and mutation during the course of infection. For recombination to occur, a single cell must be infected by two HIV strains. These coinfection events were experimentally demonstrated to occur more frequently than would be expected for independent infection events and do not follow a random distribution. Previous mathematical modeling approaches demonstrated that differences in target cell susceptibility can explain the non-randomness, both in the context of direct cell-to-cell transmission, and in the context of free virus transmission (Q. Dang et al., Proc. Natl. Acad. Sci. USA 101:632-7, 2004: K. M. Law et al., Cell reports 15:2711-83, 2016). Here, we build on these notions and provide a more detailed and extensive quantitative framework. We developed a novel mathematical model explicitly considering the heterogeneity of target cells and analysed datasets of cell-free HIV-1 single and double infection experiments in cell culture. Particularly, in contrast to the previous studies, we took into account the different susceptibility of the target cells as a continuous distribution. Interestingly, we showed that the number of infection events per cell during cell-free HIV-1 infection follows a negative-binomial distribution, and our model reproduces these datasets.
Temporal restriction of Cas9 expression improves CRISPR-mediated deletion efficacy and fidelity.
Weber J, Lang J, Carrell E, Alameh M, Davidson B Mol Ther Nucleic Acids. 2024; 35(2):102172.
PMID: 38978694 PMC: 11229411. DOI: 10.1016/j.omtn.2024.102172.
What's in a cure: designing a broad-spectrum HIV gene therapy.
Berman R, Dampier W, Nonnemacher M, Wigdahl B Curr Opin HIV AIDS. 2024; 19(3):150-156.
PMID: 38547339 PMC: 11188629. DOI: 10.1097/COH.0000000000000846.
Sunagawa J, Park H, Kim K, Komorizono R, Choi S, Ramirez Torres L Nat Commun. 2023; 14(1):7395.
PMID: 37989736 PMC: 10663562. DOI: 10.1038/s41467-023-43043-2.
Valdebenito S, Ono A, Rong L, Eugenin E NeuroImmune Pharm Ther. 2023; 2(2):169-186.
PMID: 37476291 PMC: 10355284. DOI: 10.1515/nipt-2022-0015.
Overcoming randomness does not rule out the importance of inherent randomness for functionality.
Ilan Y J Biosci. 2020; 44(6).
PMID: 31894113